CHINA PHARMA HOLDINGS, INC. Current Liabilities
CHINA PHARMA HOLDINGS, INC. (CPHI) had Current Liabilities of $7.68 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Liabilities, Current $7.68M.
- 2026-03-31: Liabilities, Current $7.27M.
- 2025-12-31: Liabilities, Current $7.40M.
- 2025-09-30: Liabilities, Current $6.62M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $7.68M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $7.27M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $7.40M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $6.62M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $5.25M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $5.12M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $5.02M 10-K · filed 2026-04-01 |
| 2024-09-30 | $4.76M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $4.71M 10-Q · filed 2024-08-14 |
| 2023-12-31 | $6.82M 10-K · filed 2025-03-31 |
| 2023-09-30 | $7.06M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $10.55M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $11.92M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $12.74M 10-K · filed 2024-04-01 |
| 2022-09-30 | $12.63M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $8.36M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $9.90M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $10.51M 10-K · filed 2023-03-30 |
| 2021-09-30 | $10.45M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $12.19M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $11.03M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $11.40M 10-K · filed 2022-03-30 |
| 2020-09-30 | $11.55M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $11.34M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $11.17M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $10.05M 10-K · filed 2021-03-26 |
| 2019-09-30 | $9.61M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $8.98M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $9.25M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $10.05M 10-K · filed 2020-03-30 |
| 2018-09-30 | $9.77M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $9.71M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $9.72M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $9.23M 10-K · filed 2019-03-28 |
| 2017-09-30 | $10.38M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $10.48M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $10.54M 10-Q · filed 2017-05-11 |
| 2016-12-31 | $10.40M 10-K · filed 2018-04-02 |
| 2016-09-30 | $12.95M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $14.10M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $14.06M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $12.79M 10-K · filed 2017-03-31 |
| 2015-09-30 | $16.13M 10-Q · filed 2015-12-28 |
| 2015-06-30 | $14.45M 10-Q · filed 2015-12-28 |
| 2015-03-31 | $14.67M 10-Q · filed 2015-12-28 |
| 2014-12-31 | $14.17M 10-K · filed 2016-03-30 |
| 2014-09-30 | $14.27M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $11.87M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $11.73M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $12.01M 10-K · filed 2015-12-28 |
| 2013-09-30 | $12.95M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $14.52M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $12.63M 10-Q · filed 2013-05-14 |
| 2012-12-31 | $14.63M 10-K · filed 2014-03-20 |
| 2012-09-30 | $16.54M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $16.56M 10-Q · filed 2012-08-14 |
| 2012-03-31 | $17.27M 10-Q · filed 2012-05-14 |
| 2011-12-31 | $13.78M 10-K · filed 2013-03-14 |
| 2011-09-30 | $13.20M 10-Q/A · filed 2012-03-06 |
| 2011-06-30 | $12.33M 10-Q/A · filed 2011-09-06 |
| 2010-12-31 | $12.81M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |